← FDA Drug Approvals (Drugs@FDA)

BRIVARACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHANDONG NEW TIME PHARMACEUTICAL CO LTD · Approved 2026-02-26

Drug application

FDA Application #

ANDA219583

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIVARACETAM

Generic name

Brivaracetam

Active ingredients

BRIVARACETAM

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

SHANDONG NEW TIME PHARMACEUTICAL CO LTD

First approval

2026-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown